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AB ~TRAC'T 
Hydroxyurea, as a 10' , cream, produces a !;iJ!niftcant im olutionary effect on psoriatic 
plaques when used under continuous plastic film occlusion . When used with only partial 
occlusion. however. the effect is only slightly better than that of the base alone. Further 
studies with the use of metabolically active derivatives of hydroxyurea and/ or different 
vehicles are warranted. 
Hydroxyurea has aroused considerable interest 
because it is a chemotherapeutic agent of a new 
class. It inhibits DNA synthesis but not R)JA or 
protein synthesis in cult~ red mammalian cells (1). 
bacteria (2), and regenerating rat liver (3). It 
inhibits the conversion of cytidylic acid to deoxy-
cytidylic acid. and it irreversibly inhibits enzyme 
protein B2 of the ribonucleotide reductase 
system. Recent studies indicate that hvdroxvurea 
i~hibits ON A synthe is and growth- of ~ouse 
embryonic and kidney cells. It also inhibits poly-
oma virus svnthesis in these cells (4). It is ac-
tive against ~ variety of experimental and human 
neoplasms including chronic myeloid leukemia 
(5). Leavell and Yarbro (6) have reported effective 
results with oral hydroxyurea in the treatment of 
psoriasis. 
In view of the ability of hydroxyurea to inhibit 
DNA synthesis without interfering with protein 
synthesis, the possibility suggested itself that the 
topical application of thi!l agent might be effec-
tive in suppressing the epidermal hyperplasia of 
psoriasis without producing cutaneous at ropl1\ 
such as is sometimes seen following the prolonged 
use of topical steroid creams under occlus ion 
MATERIALS AND METHODS 
Hydroxvuren I HlJl is wnter soluble and mll<t s a 
colo;le..... odorless suluuon It was mcorpmall·d tr1 a 
water-washahle cream. either Actd Mantle Cream 1 HI 
!Dome) or Unabase (R) (Parke-Davis). Preparations nf 
the cream hase alone and those containing HU could 
not be dbtlnJ!Utshed. In all instances, paired compari 
sons were made hetween the base containing HU and 
the same base alone. The study was conducted as 11 
double-blind. 
Treatment was re!>tricted to well-defined plaques in 
patients wil h relattvely stable psoriasis. fn mosl rn-
stanccR, comparisons were made between symmetracnlly 
located lesions, although in a few cases the plaques were 
on the same side ot the body in the same general area. A 
total of 45 paired lesions were treated in 19 adult pn 
tienL~ ( 10 men and 9 women). ,Judgment as to the clm-
ical response was based on direct observation and color 
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photographs taken with Kodarhrom!' fl :l5 mm film 
undt>r standard rondttions. 
The efficacy of the HU creams was graded (see Table) 
on the hasis of the comparatwe degree of improvement 
of the HU treated pl11que in contrast to that of the le-
saon !rented with the base alone. Thm•. if the Ill'· 
t rented lestnn sh1mt>d · :l (marked) degree ot improve-
ment 11nd the base-treated lesion showed a • 1 rmild) 
amprU\ement in favor of the Hl.J-treated leston. The 
tmprovement tn favor of the HU treated lesion The 
evaluations were made at the end of the lreatment pe 
rand 
RESLI.TS 
Initial screening trials were made with ;:,o; 25'i 
HU creams. The 5r< strength proved ineffective 
in 6 patients when applied b. i.d. for 2 weeks using 
Saran wrap occlusion at night. and in one patient 
using continuous Saran occlusion for 2 weeks. The 
2.'5~<· strength caused irritation and superficial ero-
sion in 3 patients using tt b.i.d. with continuous 
Saran. Encouragmg initial results were obtained 
with the 10', and 15°f creams and these series 
were expanded. T he results are summarized in 
the Tahle. 
In combintn!! the results of treatment with 10~ 
Hl' cream unr r ('ontinuous occlusion for 1 to 2 
" ecks. t:l nt I paired lesions treated with lO"f 
Il l! showed 1 re improvement than the base 
uJ one. This fa\orahle comparison was statistically 
signtficant as determined by the sign test (P < 
1''? ). 
In one man with symmetrical plaques on the 
dorsa of the feet, the lesions treated with 10'< HU 
cream applied b.i.d. with continuous occlusion for 
2 weeks remained completely involuted with hy-
perpigmenlation for an additional 6 weeks de-
spite the appearance of new plaques on the other 
fool treated with base alone. 
Three patients were treated b.i.d. for 2 to :l 
weeks with 10% HU in Unibase with the addition 
of 10% and 25<;t dimethylacetamide in an effort to 
improve the penetration of the HU. Saran occlu-
ston was not used. There was no improvement in 
lesions treated with the HU-dimethylacetamide 
combinations as compared to those treated with 
l'nibase alone. 
Biopsy specimens were removed from 6 lesions 
treated with a preparatton of hydroxyurea from 7 
to 14 days, and from 6 control sites treated only 
with the vehicle. Four of the lesions had received 
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TABLE 
Dtf{erent~al improt•ement of HU treated ,\itt' L'-'· ba~e alone 
~ I Ponoo Rx Pemod lmpru\·tmenl• Ill <rt'llm A.,.-tltt.'MIIIJO ~hd~ tllecu lr--u'I\A 
r---
5'• b.i.d .. occlus. h.s. 2 wks 6 0 0 0 0 
5"1 ". contin. occlus. 2 wks I () 0 0 0 
10~ ··. occlus. h.s. 2-9 wks 9 0 :3 lt 0 t local irritation 
10':. ". con tin . occlus. I wk II 0 I 6 0 -1 to ;. 2 erythema in 2 
IO'Jf ". con tin. occlus. 2 wks 3 0 0 I 2 0 
15"; ". occluti. h.s. 1- 4 wks 10 I 7 0 2 0 
15'l ", contin. occlus. I wk 2 lt 0 0 0 t oozing dermatitis 
25"~ ", contin. occlus. I wk :l Rx in all stopped due to 
dermatitis. 
----
l slightly worse: 0 no difference: + 1 slightly belter; 2 moderately better; +-3 markedly better. 
Fir.. I. Control lesion of psoriasis treated with Unibase (Rl under rontinuous occlusion for 1 week, biopsied after 
2 weeks Parakcratosib ib prominent and the s tratum granulosum ih practically abRent. Hematoxylin~eosin: " 300. 
10% HU under continuous occlusion. In two in-
stances occlusion was maintained at night only; 
in one of these 15"!- HU was used. These lesions 
all showed some degree of clinical response. AIJ 
were biopsied 2 week~; after the onset of treat-
ment (Figs. 1, 2). 
The histological changes were related more 
closely to the clinical response than to the char-
acter of the treatment. 
The most pronounced change in a treated le-
bion was a reduction in epidermal thickness to 
less than half of that of the control. with complete 
return of a normal appearing granular layer and 
loss of parakeratosis, while the control still exhib-
ited extensive parakeratosis and absence of kera-
tohyalin granules. Other lesions showed only a 
mild reduction in epidermal thickness and In· 
romplete return of normal keratinization. 
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FIG. 2. Psoriatic plaque trom the same case 1reated with II)", lit in tTnihase tRl under continuous occ-lusJcm for 
1 week. hinpsied after 2 weeks. The epidermis is ahout half thE' thi<'knrss of the control. parakeratos1~ is ab~ent and 
a stratum granulosurn is well formed. Hematoxylin ensin; :100. 
There was moderate to marked reduction in the 
number of epidermal mitotic figures as compared 
to the control specimens. There was mild basal 
epidermal edema in some instances. and an occa-
sional epidermal cell in or ncar the basal layer 
was shrunken and contained a pyknotic nucleus. 
Otherwise the epidermis showed no distinct evi-
dence of injury. Cellular infiltration in the dermis 
was comparable to that in the cont rol specimens. 
DISCUSSION 
A good clinical response wru; obtained with the 
1011: HU cream. as compared to the base, when 
used under continuous occlusion. \Vhen used with 
occlusion at night only, however, the effect of the 
10% and 150f HU creams was only slightly better 
than that of the base alone. Since continuous oc-
clusion is impractical for most patients except 
those hospitalized, it appears that. at least with 
the present formulations, HU has limited value in 
the management of psoriasis. A favorable feature 
of the HU creams is that they are odorless. color-
less, and do not stain. 
This study evaluated the effect of HU prepara-
tions on isolated lesions only. An average of ap-
proximately 15 g of cream was used to treat one 
plaque for 2 weeks. Thus. with 10% HU. approxi-
mately 1.5 g of hydroxyurea, assuming complete 
absorption. would be absorbed over a 2-week pe-
riod at a rate of approximately 100 mg daily. 
Leavell and Yarbro (6) found no depression of the 
white blood cell or platelet counts or of the hemo-
globin level in patients taking 1.0 g of hydrox-
vurea daily for 4 weeks. We made no attempt to 
treat large surface areas. Since a we, concentra-
tion was necessary to achie\·e a significant result. 
it is apparent that the treatment of large surface 
areas im·olves the hazard of absorption of consid-
erable amounts of this drug. 
An encouraging feature of this study is that 
only 2 of II patients using lO't HU cream under 
continuous occlusiOn for one week developed a 
local irritation. 
Although the results with the HU formulation~ 
in this study are not sufficiently good to warrant 
the topical usc of this substance in the practical 
management of most cases of psoriasis. they are 
nevertheless encouraging. H is possible that the 
use of metabolically active derivatives of HU 
and/or other vehicles may lead to a more striking 
effect. 
The !>lllllsllcal e"aluation was made bv 1:3yron Brown. 
Ph.D.. Division of H1o~tatistics. Stanford. Uni\ersit\ 
Sc·hnol of Medicme. · 
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